메뉴 건너뛰기




Volumn 20, Issue 1, 2020, Pages

Methodological challenges of analysing COVID-19 data during the pandemic

Author keywords

[No Author keywords available]

Indexed keywords

BETACORONAVIRUS; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DATA ANALYSIS; GLOBAL HEALTH; HEALTH SURVEY; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; MEDICAL RESEARCH; PANDEMIC; VIRUS PNEUMONIA;

EID: 85083287816     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/s12874-020-00972-6     Document Type: Review
Times cited : (72)

References (35)
  • 1
    • 85083291608 scopus 로고    scopus 로고
    • Accessed 12 Apr 2020
    • World Health Organization (WHO). https://www.who.int/. Accessed 12 Apr 2020.
  • 2
    • 85079629819 scopus 로고    scopus 로고
    • COVID-19: Fighting panic with information
    • 10224.The Lancet 10.1016/S0140-6736(20)30379-2 1:STN:280:DC%2BB387ltVOmsA%3D%3D 32087777 7138040
    • The Lancet. COVID-19: fighting panic with information. Lancet. 2020;395(10224):537. https://doi.org/10.1016/S0140-6736(20)30379-2.
    • (2020) Lancet , vol.395 , pp. 537
  • 3
    • 85080979717 scopus 로고    scopus 로고
    • Open access epidemiological data from the COVID-19 outbreak.
    • Xu B, Kraemer MUG, Xu B, et al. Open access epidemiological data from the COVID-19 outbreak. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30119-5.
    • (2020) Lancet Infect Dis.
    • Xu, B.1    Kraemer, M.U.G.2    Xu, B.3
  • 4
    • 85018454702 scopus 로고    scopus 로고
    • Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: A perspective from COMBACTE's STAT-net
    • 10.1007/s00134-017-4802-4 28466147 5487537
    • Timsit J-F, de Kraker MEA, Sommer H, et al. Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-net. Intensive Care Med. 2017;43(7):1002-12. https://doi.org/10.1007/s00134-017-4802-4.
    • (2017) Intensive Care Med , vol.43 , Issue.7 , pp. 1002-1012
    • Timsit, J.-F.1    De Kraker, M.E.A.2    Sommer, H.3
  • 5
    • 84894076536 scopus 로고    scopus 로고
    • Avoidable statistical pitfalls in analyzing length of stay in intensive care units or hospitals
    • Wolkewitz M. Avoidable statistical pitfalls in analyzing length of stay in intensive care units or hospitals. Crit Care. 2014;18(1):408.
    • (2014) Crit Care , vol.18 , Issue.1 , pp. 408
    • Wolkewitz, M.1
  • 6
    • 85014224818 scopus 로고    scopus 로고
    • Survival biases lead to flawed conclusions in observational treatment studies of influenza patients
    • 10.1016/j.jclinepi.2017.01.008 28188897
    • Wolkewitz M, Schumacher M. Survival biases lead to flawed conclusions in observational treatment studies of influenza patients. J Clin Epidemiol. 2017;84:121-9. https://doi.org/10.1016/j.jclinepi.2017.01.008.
    • (2017) J Clin Epidemiol , vol.84 , pp. 121-129
    • Wolkewitz, M.1    Schumacher, M.2
  • 7
    • 84866853131 scopus 로고    scopus 로고
    • Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias
    • Wolkewitz M, Allignol A, Harbarth S, de Angelis G, Schumacher M, Beyersmann J. Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol. 2012;65(11):1171-80.
    • (2012) J Clin Epidemiol , vol.65 , Issue.11 , pp. 1171-1180
    • Wolkewitz, M.1    Allignol, A.2    Harbarth, S.3    De Angelis, G.4    Schumacher, M.5    Beyersmann, J.6
  • 9
    • 33749019488 scopus 로고    scopus 로고
    • SARS: Systematic review of treatment effects. Low D, ed
    • 10.1371/journal.pmed.0030343 1:CAS:528:DC%2BD28XhtV2iu7zF 16968120 1564166
    • Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. Low D, ed. PLoS Med. 2006;3(9):e343. https://doi.org/10.1371/journal.pmed.0030343.
    • (2006) PLoS Med , vol.3 , Issue.9 , pp. e343
    • Stockman, L.J.1    Bellamy, R.2    Garner, P.3
  • 10
    • 85079756319 scopus 로고    scopus 로고
    • Covid-19: A puzzle with many missing pieces
    • 10.1136/bmj.m627
    • Vetter P, Eckerle I, Kaiser L. Covid-19: a puzzle with many missing pieces. BMJ. 2020;1:m627. https://doi.org/10.1136/bmj.m627.
    • (2020) BMJ , vol.1 , pp. m627
    • Vetter, P.1    Eckerle, I.2    Kaiser, L.3
  • 11
    • 85079618761 scopus 로고    scopus 로고
    • Reducing mortality from 2019-nCoV: Host-directed therapies should be an option
    • 10224,10.1016/S0140-6736(20)30305-6 1:CAS:528:DC%2BB3cXisFagtro%3D 32035018 7133595
    • Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020;395(10224):e35-6. https://doi.org/10.1016/S0140-6736(20)30305-6.
    • (2020) Lancet , vol.395 , pp. e35-e36
    • Zumla, A.1    Hui, D.S.2    Azhar, E.I.3    Memish, Z.A.4    Maeurer, M.5
  • 12
    • 85079226451 scopus 로고    scopus 로고
    • 2019 novel coronavirus-important information for clinicians.
    • del Rio C, Malani PN. 2019 novel coronavirus-important information for clinicians. JAMA. 2020. https://doi.org/10.1001/jama.2020.1490.
    • (2020) JAMA.
    • Del Rio, C.1    Malani, P.N.2
  • 13
    • 85077715855 scopus 로고    scopus 로고
    • Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
    • Sheahan TP, Sims AC, Leist SR, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11. https://doi.org/10.1038/s41467-019-13940-6.
    • (2020) Nat Commun. , pp. 11
    • Sheahan, T.P.1    Sims, A.C.2    Leist, S.R.3
  • 14
    • 85079056243 scopus 로고    scopus 로고
    • Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
    • 10.1016/S0140-6736(20)30317-2 1:CAS:528:DC%2BB3cXisFaksr4%3D 32043983 7134694,10223
    • Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473-5. https://doi.org/10.1016/S0140-6736(20)30317-2.
    • (2020) Lancet , vol.395 , pp. 473-475
    • Russell, C.D.1    Millar, J.E.2    Baillie, J.K.3
  • 15
    • 85079793129 scopus 로고    scopus 로고
    • On the use of corticosteroids for 2019-nCoV pneumonia
    • 10.1016/S0140-6736(20)30361-5 1:CAS:528:DC%2BB3cXjtVarsbY%3D 32122468,10225
    • Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395(10225):683-4. https://doi.org/10.1016/S0140-6736(20)30361-5.
    • (2020) Lancet , vol.395 , pp. 683-684
    • Shang, L.1    Zhao, J.2    Hu, Y.3    Du, R.4    Cao, B.5
  • 16
    • 85080101669 scopus 로고    scopus 로고
    • Severe SARS-CoV-2 infections: Practical considerations and management strategy for intensivists.
    • February
    • Bouadma L, Lescure F-X, Lucet J-C, Yazdanpanah Y, Timsit J-F. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. February 2020. https://doi.org/10.1007/s00134-020-05967-x.
    • (2020) Intensive Care Med.
    • Bouadma, L.1    Lescure, F.-X.2    Lucet, J.-C.3    Yazdanpanah, Y.4    Timsit, J.-F.5
  • 17
    • 85079841872 scopus 로고    scopus 로고
    • Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study.
    • Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5.
    • (2020) Lancet Respir Med.
    • Yang, X.1    Yu, Y.2    Xu, J.3
  • 18
    • 85079760608 scopus 로고    scopus 로고
    • Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series
    • 10.1136/bmj.m606
    • Xu X-W, Wu X-X, Jiang X-G, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;1:m606. https://doi.org/10.1136/bmj.m606.
    • (2020) BMJ , vol.1 , pp. m606
    • Xu, X.-W.1    Wu, X.-X.2    Jiang, X.-G.3
  • 19
    • 85078761741 scopus 로고    scopus 로고
    • Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study
    • 10.1016/S0140-6736(20)30211-7 1:CAS:528:DC%2BB3cXhvFOmsb8%3D 32007143 32007143,10223
    • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/S0140-6736(20)30211-7.
    • (2020) Lancet , vol.395 , pp. 507-513
    • Chen, N.1    Zhou, M.2    Dong, X.3
  • 20
    • 85081214652 scopus 로고    scopus 로고
    • Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore.
    • Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020. https://doi.org/10.1001/jama.2020.3204.
    • (2020) JAMA.
    • Young, B.E.1    Ong, S.W.X.2    Kalimuddin, S.3
  • 21
    • 85078262578 scopus 로고    scopus 로고
    • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
    • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30183-5.
    • (2020) Lancet.
    • Huang, C.1    Wang, Y.2    Li, X.3
  • 22
    • 85079242706 scopus 로고    scopus 로고
    • Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.
    • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585.
    • (2020) JAMA.
    • Wang, D.1    Hu, B.2    Hu, C.3
  • 23
    • 85083241171 scopus 로고    scopus 로고
    • Clinical characteristics of coronavirus disease 2019 in China.
    • Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2002032.
    • (2020) New Engl J Med.
    • Guan, W.1    Ni, Z.2    Hu, Y.3
  • 24
    • 85083545281 scopus 로고    scopus 로고
    • Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: A multicenter observational study.
    • Arabi YM, Shalhoub S, Mandourah Y, et al. Ribavirin and interferon therapy for critically ill patients with Middle East respiratory syndrome: a multicenter observational study. Clin Infect Dis. https://doi.org/10.1093/cid/ciz544.
    • Clin Infect Dis.
    • Arabi, Y.M.1    Shalhoub, S.2    Mandourah, Y.3
  • 25
    • 85045205939 scopus 로고    scopus 로고
    • Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome
    • 10.1164/rccm.201706-1172OC 29161116
    • Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med. 2018;197(6):757-67. https://doi.org/10.1164/rccm.201706-1172OC.
    • (2018) Am J Respir Crit Care Med , vol.197 , Issue.6 , pp. 757-767
    • Arabi, Y.M.1    Mandourah, Y.2    Al-Hameed, F.3
  • 26
    • 84977537867 scopus 로고    scopus 로고
    • The influence of corticosteroid treatment on the outcome of influenza a(H1N1pdm09)-related critical illness.
    • Delaney JW, Pinto R, Long J, et al. The influence of corticosteroid treatment on the outcome of influenza a(H1N1pdm09)-related critical illness. Crit Care. 2016;20. https://doi.org/10.1186/s13054-016-1230-8.
    • (2016) Crit Care. , pp. 20
    • Delaney, J.W.1    Pinto, R.2    Long, J.3
  • 27
    • 84897142275 scopus 로고    scopus 로고
    • Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza a H1N1pdm09 virus infection: A meta-analysis of individual participant data
    • 1:CAS:528:DC%2BC2cXhtFWisLjJ
    • Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza a H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2(5):395-404.
    • (2014) Lancet Respir Med , vol.2 , Issue.5 , pp. 395-404
    • Muthuri, S.G.1    Venkatesan, S.2    Myles, P.R.3
  • 28
    • 85082474264 scopus 로고    scopus 로고
    • A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19.
    • Cao B, Wang Y, Wen D, et al. A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19. New Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001282.
    • (2020) New Engl J Med.
    • Cao, B.1    Wang, Y.2    Wen, D.3
  • 29
    • 85083291108 scopus 로고    scopus 로고
    • Accessed 4 Mar 2020
    • Global research on coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov. Accessed 4 Mar 2020.
    • Global Research on Coronavirus Disease (COVID-19).
  • 30
    • 85064665026 scopus 로고    scopus 로고
    • Following Cochrane review protocols to completion 10 years later: A retrospective cohort study and author survey
    • 10.1016/j.jclinepi.2019.03.006 30928507
    • Runjic E, Behmen D, Pieper D, et al. Following Cochrane review protocols to completion 10 years later: a retrospective cohort study and author survey. J Clin Epidemiol. 2019;111:41-8. https://doi.org/10.1016/j.jclinepi.2019.03.006.
    • (2019) J Clin Epidemiol , vol.111 , pp. 41-48
    • Runjic, E.1    Behmen, D.2    Pieper, D.3
  • 31
    • 85072851985 scopus 로고    scopus 로고
    • Half of systematic reviews about pain registered in PROSPERO were not published and the majority had inaccurate status
    • 10.1016/j.jclinepi.2019.08.010 31476376
    • Runjic E, Rombey T, Pieper D, Puljak L. Half of systematic reviews about pain registered in PROSPERO were not published and the majority had inaccurate status. J Clin Epidemiol. 2019;116:114-21. https://doi.org/10.1016/j.jclinepi.2019.08.010.
    • (2019) J Clin Epidemiol , vol.116 , pp. 114-121
    • Runjic, E.1    Rombey, T.2    Pieper, D.3    Puljak, L.4
  • 32
    • 85060921095 scopus 로고    scopus 로고
    • Knowledge synthesis in evidence-based medicine
    • 10.1053/j.semnuclmed.2018.11.006 1:STN:280:DC%2BB3cfovFOktw%3D%3D 30819393
    • Garritty C, Stevens A, Hamel C, Golfam M, Hutton B, Wolfe D. Knowledge synthesis in evidence-based medicine. Semin Nucl Med. 2019;49(2):136-44. https://doi.org/10.1053/j.semnuclmed.2018.11.006.
    • (2019) Semin Nucl Med , vol.49 , Issue.2 , pp. 136-144
    • Garritty, C.1    Stevens, A.2    Hamel, C.3    Golfam, M.4    Hutton, B.5    Wolfe, D.6
  • 33
    • 85067131976 scopus 로고    scopus 로고
    • A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot
    • 10.1186/s12916-019-1338-1 31185979 6560772
    • Sigfrid L, Moore C, Salam AP, et al. A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot. BMC Med. 2019;17(1):107. https://doi.org/10.1186/s12916-019-1338-1.
    • (2019) BMC Med , vol.17 , Issue.1 , pp. 107
    • Sigfrid, L.1    Moore, C.2    Salam, A.P.3
  • 34
    • 84968756815 scopus 로고    scopus 로고
    • Quality of conduct and reporting in rapid reviews: An exploration of compliance with PRISMA and AMSTAR guidelines
    • 10.1186/s13643-016-0258-9 27160255 4862155
    • Kelly SE, Moher D, Clifford TJ. Quality of conduct and reporting in rapid reviews: an exploration of compliance with PRISMA and AMSTAR guidelines. Syst Rev. 2016;5:79. https://doi.org/10.1186/s13643-016-0258-9.
    • (2016) Syst Rev , vol.5 , pp. 79
    • Kelly, S.E.1    Moher, D.2    Clifford, T.J.3
  • 35
    • 84961291709 scopus 로고    scopus 로고
    • Developing global norms for sharing data and results during public health emergencies
    • 10.1371/journal.pmed.1001935 26731342 4701443
    • Modjarrad K, Moorthy VS, Millett P, Gsell P-S, Roth C, Kieny M-P. Developing global norms for sharing data and results during public health emergencies. PLoS Med. 2016;13(1):e1001935. https://doi.org/10.1371/journal.pmed.1001935.
    • (2016) PLoS Med , vol.13 , Issue.1 , pp. e1001935
    • Modjarrad, K.1    Moorthy, V.S.2    Millett, P.3    Gsell, P.-S.4    Roth, C.5    Kieny, M.-P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.